tiprankstipranks
Advertisement
Advertisement
Adlai Nortye submits clinical trial notification to Australia TGA for AN4035
PremiumThe FlyAdlai Nortye submits clinical trial notification to Australia TGA for AN4035
1M ago
Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway
Premium
Ratings
Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway
1M ago
Adlai Nortye Begins Weekly Dosing Arm in Global Phase 1 Trial of RAS Inhibitor AN9025
Premium
Company Announcements
Adlai Nortye Begins Weekly Dosing Arm in Global Phase 1 Trial of RAS Inhibitor AN9025
2M ago
Adlai Nortye initiated with an Outperform at Oppenheimer
PremiumThe FlyAdlai Nortye initiated with an Outperform at Oppenheimer
3M ago
Adlai Nortye initiated with a Buy at JonesResearch
Premium
The Fly
Adlai Nortye initiated with a Buy at JonesResearch
4M ago
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright
Premium
The Fly
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright
5M ago
Leerink bullish on Adlai Nortye, initiates with an Outperform
PremiumThe FlyLeerink bullish on Adlai Nortye, initiates with an Outperform
6M ago
Adlai Nortye initiated with an Outperform at Leerink
Premium
The Fly
Adlai Nortye initiated with an Outperform at Leerink
6M ago
Adlai Nortye files to sell $600M of Class A ordinary shares
Premium
The Fly
Adlai Nortye files to sell $600M of Class A ordinary shares
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100